TG
PGEN icon

TCW Group’s Precigen PGEN Stock Holding History

TCW Group’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-86,473
Closed -$2.17M – 757
2014
Q1 		$2.17M Buy
86,473
+9,377
+12% +$260K 0.01% 656
2013
Q4 		$1.75M Sell
77,096
-24,991
-24% -$505K 0.01% 680
2013
Q3 		$2.31M Buy
+102,087
New +$2.36M 0.01% 639

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

TCW Group's PGEN Position: Q2 2014 in Review

TCW Group sold out of Precigen (PGEN) in Q2 2014, closing a stake of 86,473 shares — an estimated $2.17M sold.

TCW Group first reported a position in PGEN in Q3 2013 and held it in 3 quarters. The position peaked at $2.31M in Q3 2013. 107 funds tracked by Wall St. Rank hold PGEN as of Q2 2014.

  • TCW Group reported no remaining Precigen position as of Q2 2014 after selling out during the quarter.
  • TCW Group sold 86,473 Precigen shares in Q2 2014, an estimated $2.17M.
  • TCW Group first reported a position in Precigen in Q3 2013 and held it in 3 quarters.
  • TCW Group's Precigen position peaked at $2.31M in Q3 2013.
  • 107 funds tracked by Wall St. Rank held Precigen as of Q2 2014.

Based on TCW Group's 13F filing for Q2 2014, filed 14 Aug 2014.